2011
DOI: 10.1111/j.1467-2995.2011.00645.x
|View full text |Cite
|
Sign up to set email alerts
|

The use of maropitant to prevent vomiting induced by epidural administration of preservative free morphine through an epidural catheter in a dog

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0
1

Year Published

2013
2013
2024
2024

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 11 publications
(3 citation statements)
references
References 6 publications
0
2
0
1
Order By: Relevance
“…The NK 1 receptor antagonist aprepitant is successfully used for preventing acute and delayed CINV . The NK 1 receptor antagonists are also effective against MS‐induced emesis in animals but not in humans . Recent findings have demonstrated that MS is associated with impaired endocannabinoid activity .…”
Section: Motion Sickness Medicationsmentioning
confidence: 99%
“…The NK 1 receptor antagonist aprepitant is successfully used for preventing acute and delayed CINV . The NK 1 receptor antagonists are also effective against MS‐induced emesis in animals but not in humans . Recent findings have demonstrated that MS is associated with impaired endocannabinoid activity .…”
Section: Motion Sickness Medicationsmentioning
confidence: 99%
“…Maropitant provides antimemetic effects by preventing the substance P from binding with the NK 1 receptors located in the vomiting center and the chemo-trigger zone [5, 23]. On the other hand, the substance P binds to the NK 1 receptors located in the dorsal horn of spinal cord with high affinity and produces increases in pain signal in cats [11].…”
mentioning
confidence: 99%
“…Em um estudo que comparou a associação da acepromazina com a morfina para o controle do vômito, foi obtida significativa redução, quando comparada ao uso de morfina isoladamente (KOH et al, 2014). No presente estudo, não foi possível verificar tal efeito antiemético da acepromazina, já que ambos os fármacos foram administrados juntos e o período de latência da morfina é menor que o da acepromazina (MATHIS et al, 2011). Para melhor aproveitar o efeito antiemético da acepromazina, talvez a aplicação com 15 a 20 minutos de antecedência da administração da morfina, possa diminuir ou excluir a ocorrência de vômito, o que é pouco aplicável na rotina.…”
Section: Resultsunclassified